Learn
We're in this together, investing in bold ideas and the founders brave enough to chase them.
The posts and insights here reflect our collective hunch, that the future's full of unknowns, and no one can predict it. But with shared perspectives and a little optimism, we just might back the ones who get it right.
The AI data centre backlash has a physical focal point: energy, water, noise. Two technologies are making that target disappear, and the deals are local.
The cadence of informed angel investing requires a reassessment of the cheque sizes. Why the maths says $1,000–$2,000 and why MooCoo is built around that answer.
A podcast on a walk, a $55bn bid, and the line I use to shock founders: Beanie Babies was eBay’s go-to-market. Here’s what that means for the wedge.
Australia is struggling to define a “startup” for its CGT carve-out. The wholesale investor test faced the same problem decades ago and chose bluntness. Here’s why that was wise.
Why pessimism is the natural default for a markets professional, why it’s structurally wrong, and how the momentum trade makes optimism the rational angel stance.
MooCoo backs Ovum AI, the health platform built to help women get taken seriously by their doctors.
After 13 years in an angel group and 80+ investments, my bias is that angels should help less. The smartest contribution is narrow, deep, and stays out of the way.
MooCoo backs Avarni, the Australian RegTech turning a brand-new compliance deadline into a finance-grade reporting platform thousands of companies are about to need.
A precise valuation model never tells you when price reverts to value. Except in one case: where the reversion has an address, and a closing window. Part three of a three-post sequence on how early-stage companies are valued.
The maths says the winner needs 30x. No one underwrites to 30x. The gap between what you price for and what you need is the whole game. Part two of a three-post sequence on how early-stage companies are valued.
How can a company with no product or customers be worth millions? It starts with what money actually is and ends with a vacant block of land. Part one of a three-post sequence on how early-stage companies are valued.
Richard Moore on right-sized angel due diligence in 2026: how AI, ESVCLP co-investment, and the deep dive call have moved the threshold for “enough.”
The CGT changes matter enough to angel investors and founders of early stage companies that I felt compelled to submit the following to the Senate Economics Legislation Committee.
Angel pitches are being read twice as AI changes how both sides of the table prepare. The bar hasn’t moved but the speed at which it gets applied has.
Richard Moore describes his unexpected angel investment framework, a falsification test that focuses his analysis and guides whether he considers a deal investable.
Mathematician turned angel investor, Richard Moore, explains why the same tool that solved derivatives pricing is the right way to think about angel portfolio construction.
